Publication Name	World Journal of Hepatology
Manuscript ID	82671
Country	China

Received	2022-12-26 05:31
Peer-Review Started	2022-12-26 05:33
To Make the First Decision
Return for Revision	2023-02-02 02:12
Revised	2023-02-20 05:56
Second Decision	2023-03-15 02:58
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-03-15 09:10
Articles in Press	2023-03-15 09:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-03-16 01:47
Publish the Manuscript Online	2023-03-22 11:20

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Emerging role of engineered exosomes in nonalcoholic fatty liver disease
Manuscript Source	Invited Manuscript
All Author List	Jian Ding, Chen Xu, Ming Xu, Xiao-Yue He, Wei-Na Li and Fei He
ORCID	Author(s) ORCID Number Fei He http://orcid.org/0000-0001-8368-5030
Funding Agency and Grant Number	Funding Agency Grant Number National Natural Science Foundation of China 81970535
Corresponding Author	Fei He, PhD, Research Associate, Department of Hepatobiliary Surgery, Xi-Jing Hospital, No. 127 Changle West Road , Xi'an 710032, Shaanxi Province, China. hefei_hefei@163.com
Key Words	Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Exosome; Engineered exosome; Targeted therapy
Core Tip	Nonalcoholic fatty liver disease (NAFLD) is the fastest growing chronic disease in the world. As the disease progresses, NAFLD can lead to liver fibrosis, cirrhosis and even liver cancer. However, a well-established treatment for NAFLD has yet to be identified. Exosomes are small extracellular vesicles secreted by cells. Owing to their high delivery efficiency and biocompatibility, exosomes are expected to become a new means of drug delivery and precise treatment for a variety of diseases, including NAFLD.
Publish Date	2023-03-22 11:20
Citation	Ding J, Xu C, Xu M, He XY, Li WN, He F. Emerging role of engineered exosomes in nonalcoholic fatty liver disease. World J Hepatol 2023; 15(3): 386-392
URL	https://www.wjgnet.com/1948-5182/full/v15/i3/386.htm
DOI	https://dx.doi.org/10.4254/wjh.v15.i3.386

Full Article (PDF)	WJH-15-386-with-cover.pdf
Full Article (Word)	WJH-15-386.docx
Manuscript File	82671_Auto_Edited-LJH-JLW.docx
Answering Reviewers	82671-Answering reviewers.pdf
Audio Core Tip	82671-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	82671-Conflict-of-interest statement.pdf
Copyright License Agreement	82671-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	82671-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	82671-Language certificate.pdf
Peer-review Report	82671-Peer-review(s).pdf
Scientific Misconduct Check	82671-Bing-Liu JH-2.jpg
Scientific Misconduct Check	82671-CrossCheck.jpg
Scientific Editor Work List	82671-Scientific editor work list.pdf